Published November 20, 2019
| Version v1
Report
Open
Analysis Report for Ingredient Obtainment & Curative Efficiency 2013/04689 Anti-Viral Formulation of Zada Pharmaceuticals & Mas Pharmaceuticals
Authors/Creators
Description
The Biotechnical Comparison & Sufficiency Report that examines and compares the novel Anti-Viral Ingredients with standard compounds regarding curative efficiency & potential, obtainment efficiency and anti-viral capacity. Compounds that are discovered and obtained by Erdal Can Alkoclar Mehmed Gursu and Eric Peterson and are currently under license issued to Zada Pharmaceuticals by Mas Pharmaceuticals